President Biden’s proposal for Medicaid and Medicare coverage for weight loss drugs such as Ozempic and Wegovy could draw opposition from the drug industry and President-elect Donald Trump’s administration. Julie Rovner, the chief Washington correspondent for Kaiser Health News, joins CBS News with more.
Related Posts
Birthright citizenship fight at Supreme Court targets nationwide injunctions
The Trump administration’s bid to enforce its birthright citizenship executive orders gives the Supreme Court an opportunity to address the…
Apr 30: CBS News 24/7, 10am ET
New GDP data shows U.S. economy shrank 0.3% in first quarter of 2025; Columbia student Mohsen Mahdawi has been released…
Tufts grad student taken into custody by federal agents in Somerville
A Tufts University international graduate student was taken into custody by federal authorities Tuesday, according to the school.